Chan KKW - Search Results

1

Evaluation of the impact of patient involvement in health technology assessments: A scoping review.

Mason RJ, Searle KM, Bombard Y, Rahmadian A, Chambers A, Mai H, Morrison M, Chan KKW, Jerzak KJ. Mason RJ, et al. Among authors: chan kkw. Int J Technol Assess Health Care. 2020 Jun;36(3):217-223. doi: 10.1017/S0266462320000239. Epub 2020 May 8. Int J Technol Assess Health Care. 2020. PMID: 32383420 Review.

2

Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.

Cheung MC, Sabharwal M, Chambers A, Han D, Sabarre KA, Chan K. Cheung MC, et al. J Clin Oncol. 2016 Apr 20;34(12):1428-9. doi: 10.1200/JCO.2015.66.4201. Epub 2016 Feb 16. J Clin Oncol. 2016. PMID: 26884567 No abstract available.

3

Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada.

Jerzak KJ, Berry S, Ko YJ, Earle C, Chan KK. Jerzak KJ, et al. Int J Cancer. 2017 May 1;140(9):2162-2167. doi: 10.1002/ijc.30637. Int J Cancer. 2017. PMID: 28220486 Free article.

4

Engaging specialist oncologists in the assessment of oncology drugs in Canada.

Evans WK, Sabharwal M, Fields A, Chan KKW, Cheung M, Chambers A. Evans WK, et al. Among authors: chan kkw. Lancet Oncol. 2017 May;18(5):573-575. doi: 10.1016/S1470-2045(17)30266-8. Lancet Oncol. 2017. PMID: 28495278 No abstract available.

5

Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?

Cheng S, McDonald EJ, Cheung MC, Arciero VS, Qureshi M, Jiang D, Ezeife D, Sabharwal M, Chambers A, Han D, Leighl N, Sabarre KA, Chan KKW. Cheng S, et al. Among authors: chan kkw. J Clin Oncol. 2017 Aug 20;35(24):2764-2771. doi: 10.1200/JCO.2016.71.6894. Epub 2017 Jun 2. J Clin Oncol. 2017. PMID: 28574778

6

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine.

Jerzak KJ, Laureano M, Elsharawi R, Kavsak P, Chan KK, Dhesy-Thind SK, Zbuk K. Jerzak KJ, et al. Hypoxia (Auckl). 2017 May 24;5:61-66. doi: 10.2147/HP.S127560. eCollection 2017. Hypoxia (Auckl). 2017. PMID: 28580363 Free PMC article.

7

The impact of cancer drug wastage on economic evaluations.

Truong J, Cheung MC, Mai H, Letargo J, Chambers A, Sabharwal M, Trudeau ME, Chan KKW. Truong J, et al. Among authors: chan kkw. Cancer. 2017 Sep 15;123(18):3583-3590. doi: 10.1002/cncr.30807. Epub 2017 Jun 22. Cancer. 2017. PMID: 28640362 Free article.

8

A network meta-analysis of the sequencing and types of systemic therapies with definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN)☆.

Jerzak KJ, Delos Santos K, Saluja R, Lien K, Lee J, Chan KKW. Jerzak KJ, et al. Among authors: chan kkw. Oral Oncol. 2017 Aug;71:1-10. doi: 10.1016/j.oraloncology.2017.05.011. Epub 2017 Jun 3. Oral Oncol. 2017. PMID: 28688674

9

Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding.

Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, Chan KKW. Srikanthan A, et al. Among authors: chan kkw. Curr Oncol. 2017 Oct;24(5):295-301. doi: 10.3747/co.24.3648. Epub 2017 Oct 25. Curr Oncol. 2017. PMID: 29089796 Free PMC article.

10

Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment.

Beca J, Husereau D, Chan KKW, Hawkins N, Hoch JS. Beca J, et al. Among authors: chan kkw. Pharmacoeconomics. 2018 Jan;36(1):7-15. doi: 10.1007/s40273-017-0583-4. Pharmacoeconomics. 2018. PMID: 29110141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page